Unified Parkinson's Disease Rating Scale

Diagnosis and management of dementia with Lewy bodies: Third report of the DLB consortium

McKeith, I. G., Dickson, D. W., Lowe, J., Emre, M., O'Brien, J. T., Feldman, H., Cummings, J., Duda, J. E., Lippa, C., Perry, E. K., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000187889.17253.b1 · Cited by 5,069

Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium

McKeith, I. G., Boeve, B. F., Dickson, D. W., Halliday, G., Taylor, J.-P., Weintraub, D., Aarsland, D., Galvin, J., Attems, J., Ballard, C. G., et al. (2017) · Neurology · doi:10.1212/wnl.0000000000004058 · Cited by 4,476

Second consensus statement on the diagnosis of multiple system atrophy

Gilman, S., Wenning, G. K., Low, P. A., Brooks, D. J., Mathias, C. J., Trojanowski, J. Q., Wood, N. W., Colosimo, C., Dürr, A., Fowler, C. J., et al. (2008) · Neurology · doi:10.1212/01.wnl.0000324625.00404.15 · Cited by 3,140

Non-motor symptoms of Parkinson's disease: diagnosis and management

Chaudhuri, K. R., Healy, D. G., & Schapira, A. H. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70373-8 · Cited by 2,807

What contributes to quality of life in patients with Parkinson's disease?

Schrag, A. (2000) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.69.3.308 · Cited by 1,380

Epidemiology and etiology of Parkinson's disease: a review of the evidence

Wirdefeldt, K., Adami, H.-O., Cole, P., Trichopoulos, D., & Mandel, J. (2011) · European Journal of Epidemiology · doi:10.1007/s10654-011-9581-6 · Cited by 1,199

The Uniform Data Set (UDS): Clinical and Cognitive Variables and Descriptive Data From Alzheimer Disease Centers

Morris, J. C., Weintraub, S., Chui, H. C., Cummings, J., DeCarli, C., Ferris, S., Foster, N. L., Galasko, D., Graff-Radford, N., Peskind, E. R., et al. (2006) · Alzheimer Disease & Associated Disorders · doi:10.1097/01.wad.0000213865.09806.92 · Cited by 950

The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort

Williams-Gray, C. H., Evans, J. R., Goris, A., Foltynie, T., Ban, M., Robbins, T. W., Brayne, C., Kolachana, B. S., Weinberger, D. R., Sawcer, S. J., et al. (2009) · Brain · doi:10.1093/brain/awp245 · Cited by 965

Enhanced or Impaired Cognitive Function in Parkinson's Disease as a Function of Dopaminergic Medication and Task Demands

Cools, R. (2001) · Cerebral Cortex · doi:10.1093/cercor/11.12.1136 · Cited by 906

Cueing training in the home improves gait-related mobility in Parkinson's disease: the RESCUE trial

Nieuwboer, A., Kwakkel, G., Rochester, L., Jones, D., van Wegen, E., Willems, A. M., Chavret, F., Hetherington, V, Baker, K., & Lim, I. (2007) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.200x.097923 · Cited by 857

Conscious expectation and unconscious conditioning in analgesic, motor, and hormonal placebo/nocebo responses

Benedetti, F., Pollo, A., Lopiano, L., Lanotte, M., Vighetti, S., & Rainero, I. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-10-04315.2003 · Cited by 788

Sensitivity and specificity of dopamine transporter imaging with 123I-FP-CIT SPECT in dementia with Lewy bodies: a phase III, multicentre study

McKeith, I., O'Brien, J., Walker, Z., Tatsch, K., Booij, J., Darcourt, J., Padovani, A., Giubbini, R., Bonuccelli, U., Volterrani, D., et al. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70057-1 · Cited by 716

Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study

Olanow, C. W., Kieburtz, K., Odin, P., Espay, A. J., Standaert, D. G., Fernandez, H. H., Vanagunas, A., Othman, A. A., Widnell, K. L., Robieson, W. Z., et al. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70293-x · Cited by 716

AAV2-GAD gene therapy for advanced Parkinson’s disease: a double-blind, sham-surgery controlled, randomised trial

LeWitt, P. A., Rezai, A. R., Leehey, M. A., Ojemann, S. G., Flaherty, A. W., Eskandar, E. N., Kostyk, S. K., Thomas, K., Sarkar, A., Siddiqui, M. S., et al. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70039-4 · Cited by 681

Gait Assessment in Parkinson's Disease: Toward an Ambulatory System for Long-Term Monitoring

Salarian, A., Russmann, H., Vingerhoets, F. J. G., Dehollain, C., Blanc, Y., Burkhard, P. R., & Aminian, K. (2004) · IEEE Transactions on Biomedical Engineering · doi:10.1109/tbme.2004.827933 · Cited by 659

Colonic inflammation in Parkinson's disease

Devos, D., Lebouvier, T., Lardeux, B., Biraud, M., Rouaud, T., Pouclet, H., Coron, E., Bruley des Varannes, S., Naveilhan, P., Nguyen, J.-M., et al. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.09.007 · Cited by 627

Monitoring Motor Fluctuations in Patients With Parkinson's Disease Using Wearable Sensors

Patel, S., Lorincz, K., Hughes, R., Huggins, N., Growdon, J., Standaert, D., Akay, M., Dy, J., Welsh, M., & Bonato, P. (2009) · IEEE Transactions on Information Technology in Biomedicine · doi:10.1109/titb.2009.2033471 · Cited by 623

New Clinical Subtypes of Parkinson Disease and Their Longitudinal Progression: A Prospective Cohort Comparison With Other Phenotypes

Fereshtehnejad, S.-M., Romenets, S. R., Anang, J. B. M., Latreille, V., Gagnon, J.-F., & Postuma, R. B. (2015) · JAMA Neurology · doi:10.1001/jamaneurol.2015.0703 · Cited by 615

Mutations in the Glucocerebrosidase Gene and Parkinson's Disease in Ashkenazi Jews

Aharon-Peretz, J., Rosenbaum, H., & Gershoni-Baruch, R. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa033277 · Cited by 597

Pramipexole for the treatment of depressive symptoms in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled trial

Barone, P., Poewe, W., Albrecht, S., Debieuvre, C., Massey, D., Rascol, O., Tolosa, E., & Weintraub, D. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70106-x · Cited by 562

Ambulatory monitoring of freezing of gait in Parkinson’s disease

Moore, S. T., MacDougall, H. G., & Ondo, W. G. (2008) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2007.08.023 · Cited by 526

Cognitive impairments in early Parkinson's disease are accompanied by reductions in activity in frontostriatal neural circuitry

Lewis, S. J. G., Dove, A., Robbins, T. W., Barker, R. A., & Owen, A. M. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-15-06351.2003 · Cited by 532

l-Dopa medication remediates cognitive inflexibility, but increases impulsivity in patients with Parkinson’s disease

Cools, R., Barker, R. A., Sahakian, B. J., & Robbins, T. W. (2003) · Neuropsychologia · doi:10.1016/s0028-3932(03)00117-9 · Cited by 516

ISway: a sensitive, valid and reliable measure of postural control

Mancini, M., Salarian, A., Carlson-Kuhta, P., Zampieri, C., King, L., Chiari, L., & Horak, F. B. (2012) · Journal of NeuroEngineering and Rehabilitation · doi:10.1186/1743-0003-9-59 · Cited by 499

The Clinically Important Difference on the Unified Parkinson's Disease Rating Scale

Shulman, L. M., Gruber-Baldini, A. L., Anderson, K. E., Fishman, P. S., Reich, S. G., & Weiner, W. J. (2010) · Archives of Neurology · doi:10.1001/archneurol.2009.295 · Cited by 494

Event-related functional magnetic resonance imaging in Parkinson's disease before and after levodopa

Haslinger, B., Erhard, P., Kämpfe, N., Boecker, H., Rummeny, E., Schwaiger, M., Conrad, B., & Ceballos-Baumann, A. O. (2001) · Brain · doi:10.1093/brain/124.3.558 · Cited by 486

Memantine in patients with Parkinson's disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, multicentre trial

Aarsland, D., Ballard, C., Walker, Z., Bostrom, F., Alves, G., Kossakowski, K., Leroi, I., Pozo-Rodriguez, F., Minthon, L., & Londos, E. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70146-2 · Cited by 459

Ten-Year Outcome of Subthalamic Stimulation in Parkinson Disease: A Blinded Evaluation

Castrioto, A. (2011) · Archives of Neurology · doi:10.1001/archneurol.2011.182 · Cited by 455

Association of Low Plasma Aβ42/Aβ40 Ratios With Increased Imminent Risk for Mild Cognitive Impairment and Alzheimer Disease

Graff-Radford, N. R., Crook, J. E., Lucas, J., Boeve, B. F., Knopman, D. S., Ivnik, R. J., Smith, G. E., Younkin, L. H., Petersen, R. C., & Younkin, S. G. (2007) · Archives of Neurology · doi:10.1001/archneur.64.3.354 · Cited by 441

The biomechanics and motor control of gait in Parkinson disease

Morris, M. E., Huxham, F., McGinley, J., Dodd, K., & Iansek, R. (2001) · Clinical Biomechanics · doi:10.1016/s0268-0033(01)00035-3 · Cited by 438

Cell type analysis of functional fetal dopamine cell suspension transplants in the striatum and substantia nigra of patients with Parkinson's disease

Mendez, I., Sanchez-Pernaute, R., Cooper, O., Viñuela, A., Ferrari, D., Björklund, L., Dagher, A., & Isacson, O. (2005) · Brain · doi:10.1093/brain/awh510 · Cited by 438

Motor and cognitive outcome in patients with Parkinson's disease 8 years after subthalamic implants

Fasano, A., Romito, L. M., Daniele, A., Piano, C., Zinno, M., Bentivoglio, A. R., & Albanese, A. (2010) · Brain · doi:10.1093/brain/awq221 · Cited by 429

Colonic biopsies to assess the neuropathology of Parkinson's disease and its relationship with symptoms

Lebouvier, T., Neunlist, M., Bruley des Varannes, S., Coron, E., Drouard, A., N'Guyen, J.-M., Chaumette, T., Tasselli, M., Paillusson, S., Flamand, M., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012728 · Cited by 427

Wearable Sensors and Systems

Bonato, P. (2010) · IEEE Engineering in Medicine and Biology Magazine · doi:10.1109/memb.2010.936554 · Cited by 423

Active Music Therapy in Parkinson’s Disease: An Integrative Method for Motor and Emotional Rehabilitation

Pacchetti, C., Mancini, F., Aglieri, R., Fundarò, C., Martignoni, E., & Nappi, G. (2000) · Psychosomatic Medicine · doi:10.1097/00006842-200005000-00012 · Cited by 420

Quantification of tremor and bradykinesia in Parkinson’s disease using a novel ambulatory monitoring system

Salarian, A., Russmann, H., Wider, C., Burkhard, P. R., Vingerhoets, F. J. G., & Aminian, K. (2007) · IEEE Transactions on Biomedical Engineering · doi:10.1109/tbme.2006.886670 · Cited by 416

Virtual reality for gait training: can it induce motor learning to enhance complex walking and reduce fall risk in patients with Parkinson's disease?

Mirelman, A., Maidan, I., Herman, T., Deutsch, J. E., Giladi, N., & Hausdorff, J. M. (2011) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glq201 · Cited by 418

Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease

Rolinski, M., Fox, C., Maidment, I., & McShane, R. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006504.pub2 · Cited by 418

Mechanisms of cognitive set flexibility in Parkinson's disease

Cools, R. (2001) · Brain · doi:10.1093/brain/124.12.2503 · Cited by 406

Amyloid Deposition Begins in the Striatum of Presenilin-1 Mutation Carriers from Two Unrelated Pedigrees

Klunk, W. E., Price, J. C., Mathis, C. A., Tsopelas, N. D., Lopresti, B. J., Ziolko, S. K., Bi, W., Hoge, J. A., Cohen, A. D., Ikonomovic, M. D., et al. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.0730-07.2007 · Cited by 389

Comparison of Two Forms of Intensive Speech Treatment for Parkinson Disease

Ramig, L. O., Countryman, S., Thompson, L. L., & Horii, Y. (1995) · Journal of Speech, Language, and Hearing Research · doi:10.1044/jshr.3806.1232 · Cited by 384

Long-term evaluation of deep brain stimulation of the thalamus

Pahwa, R., Lyons, K. E., Wilkinson, S. B., Simpson, R. K., Ondo, W. G., Tarsy, D., Norregaard, T., Hubble, J. P., Smith, D. A., Hauser, R. A., et al. (2006) · Journal of Neurosurgery · doi:10.3171/jns.2006.104.4.506 · Cited by 377

Gait asymmetry in patients with Parkinson’s disease and elderly fallers: when does the bilateral coordination of gait require attention?

Yogev, G., Plotnik, M., Peretz, C., Giladi, N., & Hausdorff, J. M. (2007) · Experimental Brain Research · doi:10.1007/s00221-006-0676-3 · Cited by 375

Cognitive correlates of cortical cholinergic denervation in Parkinson’s disease and parkinsonian dementia

Bohnen, N. I., Kaufer, D. I., Hendrickson, R., Ivanco, L. S., Lopresti, B. J., Constantine, G. M., Mathis, C. A., Davis, J. G., Moore, R. Y., & DeKosky, S. T. (2006) · Journal of Neurology · doi:10.1007/s00415-005-0971-0 · Cited by 364

The EQ-5D---a generic quality of life measure---is a useful instrument to measure quality of life in patients with Parkinson's disease

Schrag, A. (2000) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.69.1.67 · Cited by 327

Restoration of normal motor control in Parkinson’s disease during REM sleep

De Cock, V. C., Vidailhet, M., Leu, S., Texeira, A., Apartis, E., Elbaz, A., Roze, E., Willer, J. C., Derenne, J. P., Agid, Y., et al. (2007) · Brain · doi:10.1093/brain/awl363 · Cited by 321

Six weeks of intensive treadmill training improves gait and quality of life in patients with Parkinson's disease: a pilot study

Herman, T., Giladi, N., Gruendlinger, L., & Hausdorff, J. M. (2007) · Archives of Physical Medicine and Rehabilitation · doi:10.1016/j.apmr.2007.05.015 · Cited by 315

Prognosis of Mild Cognitive Impairment in Early Parkinson Disease: The Norwegian ParkWest Study

Pedersen, K. F., Larsen, J. P., Tysnes, O.-B., & Alves, G. (2013) · JAMA Neurology · doi:10.1001/jamaneurol.2013.2110 · Cited by 315

Gastrointestinal manifestations in Parkinson's disease: Prevalence and occurrence before motor symptoms

Cersosimo, M. G., Raina, G. B., Pecci, C., Pellene, A., Calandra, C. R., Gutiérrez, C., Micheli, F. E., & Benarroch, E. E. (2013) · Journal of Neurology · doi:10.1007/s00415-012-6801-2 · Cited by 314

Dopamine enhances willingness to exert effort for reward in Parkinson's disease

Chong, T. T.-J., Bonnelle, V., Manohar, S., Veromann, K.-R., Muhammed, K., Tofaris, G. K., Hu, M., & Husain, M. (2015) · Cortex · doi:10.1016/j.cortex.2015.04.003 · Cited by 276

Serum levels of brain-derived neurotrophic factor correlate with motor impairment in Parkinson’s disease

Scalzo, P., Kümmer, A., Bretas, T. L., Cardoso, F., & Teixeira, A. L. (2010) · Journal of Neurology · doi:10.1007/s00415-009-5357-2 · Cited by 299

Loss of white matter integrity is associated with gait disorders in cerebral small vessel disease

de Laat, K. F., Tuladhar, A. M., van Norden, A. G. W., Norris, D. G., Zwiers, M. P., & de Leeuw, F.-E. (2011) · Brain · doi:10.1093/brain/awq343 · Cited by 296

Dopamine Modulates the Response of the Human Amygdala: A Study in Parkinson's Disease

Tessitore, A., Hariri, A. R., Fera, F., Smith, W. G., Chase, T. N., Hyde, T. M., Weinberger, D. R., & Mattay, V. S. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-20-09099.2002 · Cited by 293

Nonlinear Progression of Parkinson Disease as Determined by Serial Positron Emission Tomographic Imaging of Striatal Fluorodopa F 18 Activity

Hilker, R., Schweitzer, K., Coburger, S., Ghaemi, M., Weisenbach, S., Jacobs, A. H., Rudolf, J., Herholz, K., & Heiss, W.-D. (2005) · Archives of Neurology · doi:10.1001/archneur.62.3.378 · Cited by 293

Effect of gait speed on gait rhythmicity in Parkinson's disease: variability of stride time and swing time respond differently

Frenkel-Toledo, S., Giladi, N., Peretz, C., Herman, T., Gruendlinger, L., & Hausdorff, J. M. (2005) · Journal of NeuroEngineering and Rehabilitation · doi:10.1186/1743-0003-2-23 · Cited by 285

Long-term effect of body weight-supported treadmill training in Parkinson's disease: a randomized controlled trial

Miyai, I., Fujimoto, Y., Yamamoto, H., Ueda, Y., Saito, T., Nozaki, S., & Kang, J. (2002) · Archives of Physical Medicine and Rehabilitation · doi:10.1053/apmr.2002.34603 · Cited by 284

Identification of blood microRNAs associated to Parkinsońs disease

Margis, R., Margis, R., & Rieder, C. R. M. (2011) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2011.01.023 · Cited by 263

Pathological gambling in Parkinson's disease improves on chronic subthalamic nucleus stimulation

Ardouin, C., Voon, V., Worbe, Y., Abouazar, N., Czernecki, V., Hosseini, H., Pelissolo, A., Moro, E., Lhommée, E., Lang, A. E., et al. (2006) · Movement Disorders · doi:10.1002/mds.21098 · Cited by 261

Anxiety, depression and psychosis in vascular dementia: prevalence and associations

Ballard, C., Neill, D., O’Brien, J., McKeith, I. G., Ince, P., & Perry, R. (2000) · Journal of Affective Disorders · doi:10.1016/s0165-0327(99)00057-9 · Cited by 257

Frequency of dementia, depression, and other neuropsychiatric symptoms in 1,449 outpatients with Parkinson's disease

Riedel, O., Klotsche, J., Spottke, A., Deuschl, G., Förstl, H., Henn, F., Heuser, I., Oertel, W., Reichmann, H., Riederer, P., et al. (2010) · Journal of Neurology · doi:10.1007/s00415-010-5465-z · Cited by 256

Cognitive impairment in 873 patients with idiopathic Parkinson's disease: Results from the German Study on Epidemiology of Parkinson's Disease with Dementia (GEPAD)

Riedel, O., Klotsche, J., Spottke, A., Deuschl, G., Förstl, H., Henn, F., Heuser, I., Oertel, W., Reichmann, H., Riederer, P., et al. (2008) · Journal of Neurology · doi:10.1007/s00415-008-0720-2 · Cited by 254

IMU-based classification of Parkinson’s disease from gait: a sensitivity analysis on sensor location and feature selection

Caramia, C., Torricelli, D., Schmid, M., Munoz-Gonzalez, A., Gonzalez-Vargas, J., Grandas, F., & Pons, J. L. (2018) · IEEE Journal of Biomedical and Health Informatics · doi:10.1109/jbhi.2018.2865218 · Cited by 243

Efficacy of a physical therapy program in patients with Parkinson’s disease: A randomized controlled trial

Ellis, T., de Goede, C. J., Feldman, R. G., Wolters, E. C., Kwakkel, G., & Wagenaar, R. C. (2005) · Archives of Physical Medicine and Rehabilitation · doi:10.1016/j.apmr.2004.08.008 · Cited by 242

What contributes to depression in Parkinson's disease?

SCHRAG, A., JAHANSHAHI, M., & QUINN, N. P. (2001) · Psychological Medicine · doi:10.1017/s0033291799003141 · Cited by 242

Postural sway as a marker of progression in Parkinson's disease: A pilot longitudinal study

Mancini, M., Carlson-Kuhta, P., Zampieri, C., Nutt, J. G., Chiari, L., & Horak, F. B. (2012) · Gait & Posture · doi:10.1016/j.gaitpost.2012.04.010 · Cited by 221

Dyskinesia after fetal cell transplantation for parkinsonism: A PET study

Ma, Y., Feigin, A., Dhawan, V., Fukuda, M., Shi, Q., Greene, P., Breeze, R., Fahn, S., Freed, C., & Eidelberg, D. (2002) · Annals of Neurology · doi:10.1002/ana.10359 · Cited by 219

Extended-release carbidopa-levodopa (IPX066) compared with immediate-release carbidopa-levodopa in patients with Parkinson's disease and motor fluctuations: a phase 3 randomised, double-blind trial

Hauser, R. A., Hsu, A., Kell, S., Espay, A. J., Sethi, K., Stacy, M., Ondo, W., O'Connell, M., & Gupta, S. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70025-5 · Cited by 210

The dynamics of resting and postural tremor in Parkinson's disease

Vaillancourt, D. E., & Newell, K. M. (2000) · Clinical Neurophysiology · doi:10.1016/s1388-2457(00)00467-3 · Cited by 210

Initiation of pharmacological therapy in Parkinson's disease: when, why, and how

de Bie, R. M. A., Clarke, C. E., Espay, A. J., Fox, S. H., & Lang, A. E. (2020) · The Lancet Neurology · doi:10.1016/s1474-4422(20)30036-3 · Cited by 200

Randomized, Double-blind, Placebo-Controlled Trial on Symptomatic Effects of Coenzyme Q10 in Parkinson Disease

Storch, A. (2007) · Archives of Neurology · doi:10.1001/archneur.64.7.nct60005 · Cited by 205

The Effects of Highly Challenging Balance Training in Elderly With Parkinson’s Disease: A Randomized Controlled Trial

Conradsson, D., Löfgren, N., Nero, H., Hagströmer, M., Ståhle, A., Lökk, J., & Franzén, E. (2015) · Neurorehabilitation and neural repair · doi:10.1177/1545968314567150 · Cited by 205

Autonomous identification of freezing of gait in Parkinson's disease from lower-body segmental accelerometry

Moore, S. T., Yungher, D. A., Morris, T. R., Dilda, V., MacDougall, H. G., Shine, J. M., Naismith, S. L., & Lewis, S. J. (2013) · Journal of NeuroEngineering and Rehabilitation · doi:10.1186/1743-0003-10-19 · Cited by 204

Trial of CBT for impulse control behaviors affecting Parkinson patients and their caregivers

Okai, D., Askey-Jones, S., Samuel, M., O’Sullivan, S. S., Chaudhuri, K. R., Martin, A., Mack, J., Brown, R. G., & David, A. S. (2013) · Neurology · doi:10.1212/wnl.0b013e3182840678 · Cited by 202

Using executive heterogeneity to explore the nature of working memory deficits in Parkinson’s disease

Lewis, S. J. G., Cools, R., Robbins, T. W., Dove, A., Barker, R. A., & Owen, A. M. (2003) · Neuropsychologia · doi:10.1016/s0028-3932(02)00257-9 · Cited by 201

The serotonergic system in Parkinson's disease

Huot, P., Fox, S. H., & Brotchie, J. M. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2011.08.004 · Cited by 195

Mild cognitive impairment is common in Parkinson's disease patients with normal Mini-Mental State Examination (MMSE) scores

Mamikonyan, E., Moberg, P. J., Siderowf, A., Duda, J. E., Have, T. T., Hurtig, H. I., Stern, M. B., & Weintraub, D. (2009) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2008.05.006 · Cited by 192

18F-FDG PET and Perfusion SPECT in the Diagnosis of Alzheimer and Lewy Body Dementias

O’Brien, J. T., Firbank, M. J., Davison, C., Barnett, N., Bamford, C., Donaldson, C., Olsen, K., Herholz, K., Williams, D., & Lloyd, J. (2014) · Journal of Nuclear Medicine · doi:10.2967/jnumed.114.143347 · Cited by 192

The Immediate Effect of Attentional, Auditory, and a Combined Cue Strategy on Gait During Single and Dual Tasks in Parkinson’s Disease

Baker, K., Rochester, L., & Nieuwboer, A. (2007) · Archives of Physical Medicine and Rehabilitation · doi:10.1016/j.apmr.2007.07.026 · Cited by 191

Characteristics of Visual Hallucinations in Parkinson Disease Dementia and Dementia With Lewy Bodies

Mosimann, U. P., Rowan, E. N., Partington, C. E., Collerton, D., Littlewood, E., O'Brien, J. T., Burn, D. J., & McKeith, I. G. (2006) · The American Journal of Geriatric Psychiatry · doi:10.1097/01.jgp.0000192480.89813.80 · Cited by 188

Unobtrusive assessment of activity patterns associated with mild cognitive impairment

Hayes, T. L., Abendroth, F., Adami, A., Pavel, M., Zitzelberger, T. A., & Kaye, J. A. (2008) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2008.07.004 · Cited by 187

Brain injury biomarkers are not dependent on β‐amyloid in normal elderly

Knopman, D. S., Jack, C. R., Wiste, H. J., Weigand, S. D., Vemuri, P., Lowe, V. J., Kantarci, K., Gunter, J. L., Senjem, M. L., Mielke, M. M., et al. (2013) · Annals of Neurology · doi:10.1002/ana.23816 · Cited by 183

Dopamine Cell Implantation in Parkinson's Disease: Long-Term Clinical and 18F-FDOPA PET Outcomes

Ma, Y., Tang, C., Chaly, T., Greene, P., Breeze, R., Fahn, S., Freed, C., Dhawan, V., & Eidelberg, D. (2010) · Journal of Nuclear Medicine · doi:10.2967/jnumed.109.066811 · Cited by 185

Depression and anxiety related subtypes in Parkinson's disease

Brown, R. G., Landau, S., Hindle, J. V., Playfer, J., Samuel, M., Wilson, K. C., Hurt, C. S., Anderson, R. J., Carnell, J., Dickinson, L., et al. (2011) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2010.213652 · Cited by 183

Serum levels of interleukin-6 are elevated in patients with Parkinson's disease and correlate with physical performance

Scalzo, P., Kümmer, A., Cardoso, F., & Teixeira, A. L. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2009.10.062 · Cited by 175

Sleep Disruption in Parkinson's Disease: Assessment by Continuous Activity Monitoring

van Hilten, B. (1994) · Archives of Neurology · doi:10.1001/archneur.1994.00540210094018 · Cited by 166

Wearable sensor-based objective assessment of motor symptoms in Parkinson’s disease

Ossig, C., Antonini, A., Buhmann, C., Classen, J., Csoti, I., Falkenburger, B., Schwarz, M., Winkler, J., & Storch, A. (2016) · Journal of Neural Transmission · doi:10.1007/s00702-015-1439-8 · Cited by 164

The effect of age of onset of PD on risk of dementia

Aarsland, D., Kvaløy, J. T., Andersen, K., Larsen, J. P., Tang, M. X., Lolk, A., Kragh-Sørensen, P., & Marder, K. (2007) · Journal of Neurology · doi:10.1007/s00415-006-0234-8 · Cited by 162

Basal ganglia dysfunction in OCD: Subthalamic neuronal activity correlates with symptoms severity and predicts high-frequency stimulation efficacy

Welter, M.-L., Burbaud, P., Fernandez-Vidal, S., Bardinet, E., Coste, J., Piallat, B., Borg, M., Besnard, S., Sauleau, P., Devaux, B., et al. (2011) · Translational Psychiatry · doi:10.1038/tp.2011.5 · Cited by 160

Pattern of brain atrophy rates in autopsy-confirmed dementia with Lewy bodies

Nedelska, Z., Ferman, T. J., Boeve, B. F., Przybelski, S. A., Lesnick, T. G., Murray, M. E., Gunter, J. L., Senjem, M. L., Vemuri, P., Smith, G. E., et al. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.07.005 · Cited by 155

Redox status of plasma coenzyme Q10 indicates elevated systemic oxidative stress in Parkinson's disease

Sohmiya, M., Tanaka, M., Wei Tak, N., Yanagisawa, M., Tanino, Y., Suzuki, Y., Okamoto, K., & Yamamoto, Y. (2004) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2004.05.007 · Cited by 143

A Prospective Study of Chronic Obstructive Pulmonary Disease and the Risk for Mild Cognitive Impairment

Singh, B., Mielke, M. M., Parsaik, A. K., Cha, R. H., Roberts, R. O., Scanlon, P. D., Geda, Y. E., Christianson, T. J., Pankratz, V. S., & Petersen, R. C. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2014.94 · Cited by 143

Disturbances in melatonin secretion and circadian sleep-wake regulation in Parkinson disease

Bolitho, S. J., Naismith, S. L., Rajaratnam, S. M. W., Grunstein, R. R., Hodges, J. R., Terpening, Z., Rogers, N., & Lewis, S. J. G. (2014) · Sleep Medicine · doi:10.1016/j.sleep.2013.10.016 · Cited by 139

Relationships among the metabolic patterns that correlate with mnemonic, visuospatial, and mood symptoms in Parkinson’s disease

Mentis, M. J., McIntosh, A. R., Perrine, K., Dhawan, V., Berlin, B., Feigin, A., Edwards, C., Mattis, P., & Eidelberg, D. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.5.746 · Cited by 136

Divergent CSF alterations in two common tauopathies: Alzheimer's disease and progressive supranuclear palsy

Wagshal, D., Sankaranarayanan, S., Guss, V., Hall, T., Berisha, F., Lobach, I., Karydas, A., Voltarelli, L., Scherling, C., Heuer, H., et al. (2015) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2014-308004 · Cited by 132

Carnisone Increases Efficiency of DOPA Therapy of Parkinson's Disease: A Pilot Study

Boldyrev, A., Fedorova, T., Stepanova, M., Dobrotvorskaya, I., Kozlova, E., Boldanova, N., Bagyeva, G., Ivanova-Smolenskaya, I., & Illarioshkin, S. (2008) · Rejuvenation Research · doi:10.1089/rej.2008.0716 · Cited by 123

Habitual versus goal-directed action control in Parkinson disease

de Wit, S., Barker, R. A., Dickinson, A. D., & Cools, R. (2011) · Journal of Cognitive Neuroscience · doi:10.1162/jocn.2010.21514 · Cited by 116

Effectiveness of Intensive Inpatient Rehabilitation Treatment on Disease Progression in Parkinsonian Patients: A Randomized Controlled Trial With 1-Year Follow-up

Frazzitta, G., Bertotti, G., Riboldazzi, G., Turla, M., Uccellini, D., Boveri, N., Guaglio, G., Perini, M., Comi, C., Balbi, P., et al. (2012) · Neurorehabilitation and neural repair · doi:10.1177/1545968311416990 · Cited by 116

Vocal Responses to Perturbations in Voice Auditory Feedback in Individuals with Parkinson's Disease

Liu, H., Wang, E. Q., Metman, L. V., & Larson, C. R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033629 · Cited by 114

A questionnaire-based (UM-PDHQ) study of hallucinations in Parkinson's disease

Papapetropoulos, S., Katzen, H., Schrag, A., Singer, C., Scanlon, B. K., Nation, D., Guevara, A., & Levin, B. (2008) · BMC Neurology · doi:10.1186/1471-2377-8-21 · Cited by 111

Home-based treadmill training for individuals with Parkinson's disease: a randomized controlled pilot trial

Canning, C. G., Allen, N. E., Dean, C. M., Goh, L., & Fung, V. S. (2012) · Clinical Rehabilitation · doi:10.1177/0269215511432652 · Cited by 108